Patriot Financial Group Insurance Agency’s Ultragenyx Pharmaceutical RARE Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-127	Closed	-$8K	–	1584
2022 Q2	$8K	Sell	127 -29	-19%	-$1.78K	﹤0.01%	1345
2022 Q1	$11K	Sell	156 -10	-6%	-$696	﹤0.01%	1328
2021 Q4	$14K	Buy	166 +2	+1%	+$163	﹤0.01%	1354
2021 Q3	$15K	Buy	164 +28	+21%	+$2.53K	﹤0.01%	1330
2021 Q2	$13K	Hold	136	–	–	﹤0.01%	1347
2021 Q1	$15K	Hold	136	–	–	﹤0.01%	1218
2020 Q4	$19K	Hold	136	–	–	﹤0.01%	1002
2020 Q3	$11K	Hold	136	–	–	﹤0.01%	1011
2020 Q2	$11K	Sell	136 -4	-3%	-$265	﹤0.01%	954
2020 Q1	$6K	Buy	+140	New	+$7.27K	﹤0.01%	1029

Other funds holding RARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Patriot Financial Group Insurance Agency's RARE Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2022, closing a stake of 127 shares — an estimated $8K sold.

Patriot Financial Group Insurance Agency first reported a position in RARE in Q1 2020 and held it in 10 quarters. The position peaked at $19K in Q4 2020. 233 funds tracked by Wall St. Rank hold RARE as of Q3 2022.

Patriot Financial Group Insurance Agency reported no remaining Ultragenyx Pharmaceutical position as of Q3 2022 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 127 Ultragenyx Pharmaceutical shares in Q3 2022, an estimated $8K.
Patriot Financial Group Insurance Agency first reported a position in Ultragenyx Pharmaceutical in Q1 2020 and held it in 10 quarters.
Patriot Financial Group Insurance Agency's Ultragenyx Pharmaceutical position peaked at $19K in Q4 2020.
233 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.